Advertisement
Screener

Orthofix Medical Inc. (OFIX) Overview

Orthofix Medical Inc. (OFIX) Overview

  • 1 Apr 2026: Period ending 30 Jun 2026; Estimate (m); Actual -0.39; Beat / miss (m).
  • 1 Jan 2026: Period ending 31 Mar 2026; Estimate (m); Actual -0.52; Beat / miss (m).
  • 1 Jul 2025: Period ending 30 Sept 2025; Estimate (m); Actual -0.57; Beat / miss (m).
  • 1 Apr 2025: Period ending 30 Jun 2025; Estimate (m); Actual -0.36; Beat / miss (m).

Stock Price Chart

View more →

Blue: Split-adjusted close · Orange: Cumulative dividend-reinvested close

$7.47$8.80$10.38$12.24$14.43$17.012025-11-062026-11-06$7.47$10.32$14.26$19.70$27.23$37.622021-11-082026-11-06$7.47$11.72$18.39$28.86$45.30$71.102016-11-072026-11-06$7.47$11.72$18.39$28.86$45.30$71.102006-11-062026-11-06$5.59$9.29$15.45$25.70$42.75$71.101992-04-242026-11-06

Logarithmic scale. Both lines share the same starting value for the selected range.

Last close
$7.86
Previous close
$9.75
Change
-$1.89
Change (%)
-19.38%
Close date
2026-11-06
Previous close date
2026-09-29
Open
(m)
Day high
(m)
Day low
(m)
Last session volume
(m)
Last session value
(m)
Currency
USD
Price basis
split-adjusted
Volume basis
(m)

Performance

View more →

Cumulative total returns · 2026-09-29

YTD

OFIX
-35.69%
S&P 500
(m)

1 year

OFIX
-32.10%
S&P 500
(m)

3 years

OFIX
-24.18%
S&P 500
(m)

5 years

OFIX
-74.39%
S&P 500
(m)

Earnings trends

View more →

Earnings per share

USD / share · As filed

30 Jun 2026 ○ Estimate (m) ● Actual -0.39

-1.43-1.12-0.81-0.49-0.1831 Mar 2025: estimate (m); actual -1.3531 Mar 2025(m)30 Jun 2025: estimate (m); actual -0.3630 Jun 2025(m)30 Sept 2025: estimate (m); actual -0.5730 Sept 2025(m)31 Mar 2026: estimate (m); actual -0.5231 Mar 2026(m)30 Jun 2026: estimate (m); actual -0.3930 Jun 2026(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Apr 202630 Jun 2026(m)-0.39(m)(m)
1 Jan 202631 Mar 2026(m)-0.52(m)(m)
1 Jul 202530 Sept 2025(m)-0.57(m)(m)
1 Apr 202530 Jun 2025(m)-0.36(m)(m)
1 Jan 202531 Mar 2025(m)-1.35(m)(m)

31 Dec 2025 ○ Estimate (m) ● Actual -2.33

-4.20-3.35-2.50-1.65-0.8031 Dec 2021: estimate (m); actual -1.9531 Dec 2021(m)31 Dec 2022: estimate (m); actual -0.9831 Dec 2022(m)31 Dec 2023: estimate (m); actual -4.1231 Dec 2023(m)31 Dec 2024: estimate (m); actual -3.3031 Dec 2024(m)31 Dec 2025: estimate (m); actual -2.3331 Dec 2025(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Jan 202531 Dec 2025(m)-2.33(m)(m)
1 Jan 202431 Dec 2024(m)-3.30(m)(m)
1 Jan 202331 Dec 2023(m)-4.12(m)(m)
1 Jan 202231 Dec 2022(m)-0.98(m)(m)
1 Jan 202131 Dec 2021(m)-1.95(m)(m)

Revenue vs. Earnings

USD

30 Jun 2026 ■ Revenue 210.93M ■ Earnings -15.80M — Profit margin -7.49%

-51.92M-12.1%48.40M-8.1%148.72M-4.0%249.04M-0.0%30 Sept 2025: revenue 205.63M; earnings -22.80M; profit margin -11.09%30 Sept 202531 Dec 2025: revenue 219.91M*; earnings -2.22M*; profit margin -1.01%*; Revenue: Annual amount − nine-month amount; Earnings: Annual amount − nine-month amount; period 2025-10-01 to 2025-12-31; USD.31 Dec 202531 Mar 2026: revenue 196.71M; earnings -20.91M; profit margin -10.63%31 Mar 202630 Jun 2026: revenue 210.93M; earnings -15.80M; profit margin -7.49%30 Jun 2026

31 Dec 2025 ■ Revenue 822.31M ■ Earnings -92.19M — Profit margin -11.21%

-268.25M-21.3%134.22M-15.3%536.69M-9.3%939.16M-3.3%31 Dec 2022: revenue 460.71M; earnings -19.75M; profit margin -4.29%31 Dec 202231 Dec 2023: revenue 746.64M; earnings -151.40M; profit margin -20.28%31 Dec 202331 Dec 2024: revenue 799.49M; earnings -126.00M; profit margin -15.76%31 Dec 202431 Dec 2025: revenue 822.31M; earnings -92.19M; profit margin -11.21%31 Dec 2025

Analyst insights

View more →
RatingsBuyHoldSellOther ratingsLast CloseAverage TargetUpsideHigh TargetLow Target
(m)(m)(m)(m)(m)$7.86(m)(m)(m)(m)
Past 12 Months12 Month ForecastLast Close$7.86High(m)Average(m)Low(m)2025-11-062026-11-06

Recent news

View more →

(m)

YouTube videos mentioning OFIX

View more →

(m)

Statistics

View more →

Retained observations as of 2026-11-11; financial period ending (m).

Forward P/E
(m)
PEG ratio · 5-year expected
(m)
Shares held by insiders
(m)
Insider transactions · change (%)
(m)
Shares held by institutions
(m)
Institutional transactions · change (%)
(m)
Diluted EPS · 12 month
(m)
EPS estimate · next quarter
(m)
EPS estimate · next year
(m)
EPS growth · current annual estimate
(m)
EPS growth · next annual estimate
(m)
EPS growth · next 5 years expected
(m)
EPS growth · past 3 years annualized
(m)
EPS growth · past 5 years annualized
(m)
EPS change · 12 months vs prior year
(m)
EPS change · latest quarter vs previous quarter
(m)
Latest earnings report date
(m)
EPS surprise · latest reported quarter
(m)
Net income · 12 month
(m)
Profit margin
(m)
Return on assets · 12 month
(m)
Stock compensation expense · all employees · 12 months
(m)
Named executive and board stock awards · latest fiscal year
(m)
Index membership
(m)
IPO date
(m)
Options available
(m)
Shortable
(m)
Analyst recommendation
(m)
Analyst target price
(m)
Price volatility · week
(m)
Price volatility · month
(m)
Average true range · 14 sessions
(m)
Relative strength index · 14 sessions
(m)
Relative volume
(m)
Average daily volume
397.14K
Latest session volume
(m)
Last session value
(m)
30 days ago session value
(m)
1 year ago session value
(m)
Number of trades
(m)
Total return · week
8.57%*
Total return · month
0.52%*
Total return · quarter
0.72%*
Total return · half year
-15.22%*
Total return · year to date
-35.69%*
Total return · 1 year
-32.10%*
Total return · 3 years
-24.18%*
Total return · 5 years
-74.39%*
Market cap
(m)
Book value per share · latest quarter
(m)
Price / cash · latest quarter
(m)
Enterprise value
(m)
Enterprise value / revenue
(m)
Enterprise value / EBITDA
(m)
Dividend · 12 months per share
(m)
Dividend ex-date
(m)
Next dividend ex-date
(m)
Next dividend amount per share
(m)
Dividend growth · 3 years annualized
(m)
Dividend growth · 5 years annualized
(m)
Revenue · 12 month
(m)
Revenue growth · past 3 years annualized
(m)
Revenue growth · past 5 years annualized
(m)
Revenue change · 12 months vs prior year
(m)
Revenue change · latest quarter vs previous quarter
(m)
Revenue surprise · latest reported quarter
(m)
Levered free cash flow · 12 month
(m)
Debt / equity · latest quarter
(m)
Long-term debt / equity · latest quarter
(m)
Return on equity · 12 month
(m)
Return on invested capital · 12 months
(m)
Previous close
(m)
Latest closing price
(m)
Latest session change (%)
(m)
52-week high
(m)
52-week low
(m)
Price vs 20-session moving average
(m)
Price vs 50-session moving average
(m)
Price vs 200-session moving average
(m)
Float shares
(m)
Short float (%)
(m)
Short ratio (days to cover)
(m)
Short interest (shares)
(m)

Five-year projected P/E and P/S repeat the preceding five-year EPS and revenue CAGR, holding current price and market cap constant. Hover a calculated row for its formula. Net assets = assets − debt − payables − deferred revenue − obligations due within 1 year − obligations due after 1 year.

Holders breakdown

View more →
BreakdownOwnership
(m)Shares held by all insiders
(m)Shares held by institutions
(m)Float held by institutions
(m)Institutions holding shares

Other holders

(m)

View more →

Insider holders

(m)

View more →

Top institutional holders

(m)

View more →

Top mutual fund holders

(m)

View more →

Orthofix Medical Inc. Overview

View more →

(m)

(m)

SEC CIK
884624
Industry (SIC)
3841 Surgical & Medical Instruments & Apparatus
Country of operation
United States
Business address
3451 PLANO PARKWAY, LEWISVILLE, Texas, 75056, United States
Fiscal year end
1223
Phone
214-937-2000

Similar stocks

Stock NameCountryMarket CapPE Ratio
Orchestra BioMed Holdings, Inc. (OBIO)United States$0.356B-4.39
SHOULDER INNOVATIONS, INC. (SI)United States$0.355B
CARLSMED, INC. (CARL)United States$0.405B
Embecta Corp. (EMBC)United States$0.319B2.10
ClearPoint Neuro, Inc. (CLPT)United States$0.446B-15.74
TREACE MEDICAL CONCEPTS, INC. (TMCI)United States$0.297B-4.32
Mobia Medical, Inc. (MOBI)United States$0.293B
TriSalus Life Sciences, Inc. (TLSI)United States$0.283B-9.92
Cytosorbents Corp (CTSO)United States$0.274B-1.29
ORASURE TECHNOLOGIES INC (OSUR)United States$0.272B-6.26